Huperzine A (HupA) was first isolated from H. serrata in the 1980s and was approved in the 1990s in China as an acetylcholinesterase inhibitor (AChEI) to treat Alzheimer’s disease (AD). Here, ACHE is linked to Alzheimer disease.